statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Pluri trading halted, news pending

Pluri's business verticals leverage Company's world-leading 3D cell expansion know-how, IP, and manufacturing facility to drive revenue and bring innovative cell-based solutions to numerous...

Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

Pluri Inc. (NASDAQ:PLUR  Free Report) shares are going to reverse split on the morning of Monday, April 1st. The 1-8 reverse split was announced on Monday, April 1st. The number of shares...

Pluri (NASDAQ:PLUR) Shares to Reverse Split on Monday, April 1st

Pluri Inc. (NASDAQ:PLUR  Free Report)s stock is scheduled to reverse split on the morning of Monday, April 1st. The 1-8 reverse split was announced on Monday, April 1st. The number of...

Pluri (NASDAQ:PLUR) Shares Set to Reverse Split on Monday, April 1st

HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the Company"), a leading biotechnology company that transforms cells into solutions, today...

Pluri Inc. Announces 1-for-8 Reverse Share Split

Pluri addresses challenges revealed in ICO market report

International Coffee Organization (ICO) Market Report published on March 7, 2024 highlights alarming price instability challenging the coffee industryAccording to the report, adverse weather...

Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote...

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

Pluri selected as CDMO by Remedy Cell for cell-free drug manufacturing

PluriCDMO will support Remedy Cell in the manufacture of RC-0315 product candidate for the treatment of Idiopathic Pulmonary Fibrosis (IPF)HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri...

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.

Volume	21,388.00
52-Wk High	$8.56
52-Wk Low	$3.45

PLUR Pluri Inc

About

Feed

News

Sentiment

Fundamentals